Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Low doses of Asiasari radix extract boost stem cell growth without changing their shape.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Benzoyl peroxide and adapalene gels work differently to reduce acne in mice.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Finasteride helps reduce lung inflammation and damage after trauma and infection.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.